The British pharmaceutical giant GlaxoSmithKline Plc, announced an increase in net profits and sales in the last quarter of 2021.
The company said net profit stood at 9 749m ($ 1.01bn) for the fourth quarter, up from 67 677m a year ago, while sales rose to ,5 9.53bn. from ,7 8.74 billion.
While sales exceeded expectations, net profits were lower than expected, at 19 1.19 billion.
Earnings per share rose to 14.7 pence from 13.6 pence, while adjusted earnings per share stood at 25.6 pence, against estimates for 23.8 pence.
The company announced a dividend of 23 pence for the fourth quarter and 80 pence for 2021, respectively according to estimates.
Glaxo said it expects sales growth in 2022 between 5% -7% at a stable exchange rate.
Adjusted operating profit is expected to increase 12% -14% in fixed currency during the year.
Glaxo estimates that the breakdown of consumer health activities will take place in 2022.
Source: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
